Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells

scientific article published on 7 November 2016

Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.13175
P932PMC publication ID5356688
P698PubMed publication ID27835867

P50authorStefan MrdenovicQ57016572
P2093author name stringMichael R Freeman
Leland W K Chung
Haiyen E Zhau
Sungyong You
Michael S Lewis
Yi-Tsung Lu
Jayoung Kim
Jen-Ming Huang
Ruoxiang Wang
Lijuan Yin
Quanlin Li
Isla Garraway
Qinlong Li
Lawrence W Jones
Gina C-Y Chu
Jason B-Y Wu
P2860cites workFOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancerQ24307471
Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cellsQ24641991
Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18Q28202540
Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancerQ28478514
Plexin A3 and plexin A4 convey semaphorin signals during facial nerve developmentQ28506942
Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative studyQ30417094
Collective invasion in breast cancer requires a conserved basal epithelial programQ30573307
Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.Q31146575
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cellsQ33645250
Identification of methylated genes associated with aggressive bladder cancerQ33680247
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.Q34192343
Keratin 8/18 regulation of cell stiffness-extracellular matrix interplay through modulation of Rho-mediated actin cytoskeleton dynamicsQ34299746
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancerQ34340156
Serpins promote cancer cell survival and vascular co-option in brain metastasisQ34407528
Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin SQ34599128
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse modelQ34639081
Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Q35141115
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasisQ35190722
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrierQ35407588
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort studyQ35683537
Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 ExpressionQ35861040
Differentiation potential of urothelium from patients with benign bladder dysfunctionQ35966453
Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosisQ36494588
Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patientsQ36530753
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clustersQ36607592
Structural and regulatory functions of keratins.Q36791981
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.Q37301697
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonizationQ37648868
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancerQ37683681
Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapyQ38022954
Generation of clinically relevant "induced pluripotent stem" (iPS) cells.Q38069587
Reprogramming cancer cells in endocrine-related tumors: open issues.Q38168603
Characterization of prostate neuroendocrine cancers and therapeutic management: a literature reviewQ38209356
The network of epithelial-mesenchymal transition: potential new targets for tumor resistanceQ38255668
The reciprocal interactions between astrocytes and prostate cancer cells represent an early event associated with brain metastasisQ39027973
Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damageQ39534958
Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasisQ40244672
A new human prostate carcinoma cell line, 22Rv1.Q40933318
Suprabasal change and subsequent formation of disulfide-stabilized homo- and hetero-dimers of keratins during esophageal epithelial differentiation.Q42483380
Early expression of type I K13 keratin in the progression of mouse skin papillomas.Q44869872
Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytesQ46608353
Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).Q47887528
Reduced expression of cytokeratin 4 and 13 is a valuable marker for histologic grading of esophageal squamous intraepithelial neoplasiaQ47906877
Distribution of metastatic sites in patients with prostate cancer: A population-based analysisQ48929994
Semaphorin signaling in bone.Q50936117
Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervixQ71649289
Keratin mRNA for detecting micrometastasis in cervical lymph nodes of oral cancerQ73247282
Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinomaQ73711657
Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrenceQ80856745
A proteomics analysis of cell signaling alterations in colorectal cancerQ81234559
A de novo missense mutation in the keratin 13 gene in oral white sponge naevusQ81616289
P433issue51
P407language of work or nameEnglishQ1860
P304page(s)84645-84657
P577publication date2016-12-01
P1433published inOncotargetQ1573155
P1476titleKeratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
P478volume7

Reverse relations

cites work (P2860)
Q41711884A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Q64064768Evidence for an oncogenic role of HOXC6 in human non-small cell lung cancer
Q61797777High Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients
Q42776923Isolation and functional interrogation of adult human prostate epithelial stem cells at single cell resolution.
Q54216107KF-finder: identification of key factors from host-microbial networks in cervical cancer.
Q47104201KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma
Q64941550Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics.
Q55289611Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.